Nociceptin Levels in the Cerebrospinal Fluid of Chronic Pain Patients With or Without Intrathecal Administration of Morphine

Journal of Pain and Symptom Management

Volumn 32, Issue 4, 2006, Pages 372-377

  Raffaeli, William ^a   Dekel, Boaz Gedaliahu Samolsky ^a   Landuzzi, Daniela ^a   Caminiti, Alessandro ^a   Righetti, Donatella ^a   Balestri, Marco ^a   Montanari, Francesco ^a   Romualdi, Patrizia ^a   Candeletti, Sanzio ^a  

^a Ospedale di Rimini   (Italy)

Author keywords

chronic noncancer pain; CSF; intrathecal morphine; Nociceptin orphanin; radioimmunoassay

Indexed keywords

MORPHINE; NOCICEPTIN; OPIATE;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; CEREBROSPINAL FLUID ANALYSIS; CHRONIC PAIN; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LONG TERM CARE; MALE; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE;

AGED; ANALGESICS, OPIOID; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MORPHINE; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT;

EID: 33748949955     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.05.013     Document Type: Article

References (22)

1. Reinscheid R.K., Nothacker H.P., Bourson A., et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 (1995) 792-794
2. Meunier J.C., Mollereau C., Toll L., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
3. Mollereau C., and Mouledous L. Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21 (2000) 907-917
4. Mollereau C., Parmentier M., Mailleux P., et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341 (1994) 33-38
5. Cox B.M., Chavkin C., Christie M.J., et al. Opioid receptors. In: Girdlestone D. (Ed). The IUPHAR compendium of receptor characterization and classification (2000), IUPHAR Media, London 321-333
6. Tian J.H., Zhang W., Fang Y., et al. Endogenous orphanin FQ: evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture. Br J Pharmacol 124 (1998) 21-26
7. Jenck F., Moreau J., Martin J., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA 94 (1997) 14854-14858
8. Ciccocioppo R., Angeletti S., Panocka I., and Massi M. Nociceptin/orphanin FQ and drugs of abuse. Peptides 21 (2000) 1071-1080
9. Mogil J.S., Grisel J.E., Reinscheid R.K., et al. Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75 (1996) 333-337
10. Xu X.J., Hao J.X., and Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport 7 (1996) 2092-2094
11. Ploj K., Roman E., Gustavsson L., and Nylander I. Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice. Brain Res Bull 53 (2000) 219-226
12. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53 (2001) 381-415
13. Meunier J.C. Utilizing functional genomics to identify new pain treatments: the example of nociceptin. Am J Pharmacogenomics 3 (2003) 117-130
14. Lutfy K., and Maidment N.T. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br J Pharmacol 131 (2000) 1684-1688
15. Candeletti S., Guerrini R., Calo G., Romualdi P., and Ferri S. Supraspinal and spinal effects of [Phe1psi(CH2-NH)Gly2]-nociceptin(1-13)-NH2 on nociception in the rat. Life Sci 66 (2000) 257-264
16. Candeletti S., and Ferri S. Effects of an antisense oligonucleotide to pronociceptin and long-term prevention of morphine actions by nociceptin. Peptides 21 (2000) 1119-1124
17. Yamamoto T., Nozaki-Taguchi N., and Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience 81 (1997) 249-254
18. Ko M.H., Kim Y.H., Woo R.S., and Kim K.W. Quantitative analysis of nociceptin in blood of patients with acute and chronic pain. Neuroreport 13 (2002) 1631-1633
19. Hantos M.B., Szalay F., Lakatos P.L., et al. Elevated plasma nociceptin level in patients with Wilson disease. Brain Res Bull 58 (2002) 311-313
20. Rosen A., Lundeberg T., Bytner B., and Nylander I. Central changes in nociceptin dynorphin B and Met-enkephalin-Arg-Phe in different models of nociception. Brain Res 857 (2000) 212-218
21. Calo' G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol 129 (2000) 1261-1283
22. Romualdi P., Landuzzi D., D'Addario C., and Candeletti S. Modulation of proorphanin FQ/N gene expression by morphine in the rat mesocorticolimbic system. Neuroreport 13 (2002) 645-648